84
59
Growth Score 84 in past quarter
-4 pts
Heat Score 59 in past quarter
-19 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
278852
A2-Ai offers AI-driven clinical pharmacology consultancy, focusing on accelerating drug development and improving patient care.
- Sunny Chapel: Founder, President and CEO
About the Company
A2-Ai specializes in technology-driven clinical pharmacology and pharmacometrics, focusing on leveraging artificial intelligence (AI) to accelerate drug development and improve patient outcomes. With a team led by experts in the field, A2-Ai offers consultancy services that prioritize science and patient care. The company utilizes modern AI,
machine learning (ML), and business intelligence (BI) tools and strategies to deliver value to clients in the pharmaceutical industry. A2-Ai also hosts an applied artificial intelligence conference in Ann Arbor, aimed at educating professionals about the latest in AI technology and its applications in clinical pharmacology.